262
Views
2
CrossRef citations to date
0
Altmetric
Short Report

First trimester ultrasound features of X-linked Opitz syndrome and early molecular diagnosis: case report and review of the literature

, , ORCID Icon, , , , , ORCID Icon, , , , , , & show all
Pages 3089-3093 | Received 03 Jul 2019, Accepted 04 Oct 2019, Published online: 21 Oct 2019

References

  • Meroni G. X-linked Opitz G/BBB syndrome. In: Adam MP, Ardinger HH, Pagon RA, editors. GeneReviews. Seattle (WA): University of Washington, Seattle; 1993.
  • Cox TC, Allen LR, Cox LL, et al. New mutations in MID1 provide support for loss of function as the cause of X-linked Opitz syndrome. Hum Mol Genet. 2000;9(17):2553–2562.
  • De Falco F, Cainarca S, Andolfi G, et al. X-linked Opitz syndrome: novel mutations in the MID1 gene and redefinition of the clinical spectrum. Am J Med Genet. 2003;120A(2):222–228.
  • Mnayer L, Khuri S, Merheby HA, et al. A structure-function study of MID1 mutations associated with a mild Opitz phenotype. Mol Genet Metab. 2006;87(3):198–203.
  • Pinson L, Augé J, Audollent S, et al. Embryonic expression of the human MID1 gene and its mutations in Opitz syndrome. J Med Genet. 2004;41(5):381–386.
  • So J, Suckow V, Kijas Z, et al. Mild phenotypes in a series of patients with Opitz GBBB syndrome with MID1 mutations. Am J Med Genet. 2005;132A(1):1–7.
  • Schweiger S, Foerster J, Lehmann T, et al. The Opitz syndrome gene product, MID1, associates with microtubules. Proc Natl Acad Sci USA. 1999;96(6):2794–2799.
  • Short KM, Hopwood B, Yi Z, et al. MID1 and MID2 homo- and heterodimerise to tether the rapamycin-sensitive PP2A regulatory subunit, alpha 4, to microtubules: implications for the clinical variability of X-linked Opitz GBBB syndrome and other developmental disorders. BMC Cell Biol. 2002;3(1):1.
  • Trockenbacher A, Suckow V, Foerster J, et al. MID1, mutated in Opitz syndrome, encodes an ubiquitin ligase that targets phosphatase 2A for degradation. Nat Genet. 2001;29(3):287–294.
  • Normand EA, Braxton A, Nassef S, et al. Clinical exome sequencing for fetuses with ultrasound abnormalities and a suspected Mendelian disorder. Genome Med. 2018;10(1):74.
  • Cicatiello R, Pignataro P, Izzo A, et al. Chromosomal microarray analysis versus karyotyping in fetuses with increased nuchal translucency. Med Sci. 2019;7(3):1–8.
  • Maruotti GM, Frisso G, Calcagno G, et al. Prenatal diagnosis of inherited diseases: 20 years’ experience of an Italian Regional Reference Centre. Clin Chem Lab Med. 2013;51(12):2211–2217.
  • Carsana A, Frisso G, Tremolaterra MR, et al. A larger spectrum of intragenic short tandem repeats improves linkage analysis and localization of intragenic recombination detection in the dystrophin gene: an analysis of 93 families from southern Italy. J Mol Diagn JMD. 2007;9(1):64–69.
  • Hogdall C, Siegel-Bartelt J, Toi A, et al. Prenatal diagnosis of Opitz (BBB) syndrome in the second trimester by ultrasound detection of hypospadias and hypertelorism. Prenat Diagn. 1989;9(11):783–793.
  • Tajima H, Itoh H, Mochizuki A, et al. Case of polyhydramnios complicated by Opitz G/BBB syndrome. J Obstet Gynaecol Res. 2010;36(4):876–881.
  • Cheng YK, Huang J, Law KM, et al. Prenatal diagnosis of maternally inherited X-linked Opitz G/BBB syndrome by chromosomal microarray in a fetus with complex congenital heart disease. Clin Chim Acta. 2014;436:140–142.
  • Spinelli M, Sica C, Dallapiccola B, et al. The challenge of prenatal diagnostic work-up of maternally inherited X-linked Opitz G/BBB: case report and literature review. Case Rep Obstet Gynecol. 2015;2015:1–5.
  • Li B, Zhou T, Zou Y. Mid1/Mid2 expression in craniofacial development and a literature review of X-linked opitz syndrome. Mol Genet Genomic Med. 2016;4(1):95–105.
  • Chaoui R, Orosz G, Heling KS, et al. Maxillary gap at 11–13 weeks’ gestation: marker of cleft lip and palate. Ultrasound Obstet Gynecol. 2015;46(6):665–669.
  • Petrovski S, Aggarwal V, Giordano JL, et al. Whole-exome sequencing in the evaluation of fetal structural anomalies: a prospective cohort study. Lancet. 2019;393(10173):758–767.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.